פמוזול

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

LETROZOLE 2.5 MG

から入手可能:

PERRIGO ISRAEL AGENCIES LTD

ATCコード:

L02BG04

医薬品形態:

FILM COATED TABLETS

投与経路:

PER OS

製:

HAUPT PHARMA MUNSTER GmbH, GERMANY

治療群:

LETROZOLE

適応症:

• Femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • Femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

承認日:

2010-11-01